These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25983162)

  • 1. What about the risk of thrombosis with bioresorbable scaffolds?
    Capodanno D; Joner M; Zimarino M
    EuroIntervention; 2015; 11 Suppl V():V181-4. PubMed ID: 25983162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bioresorbable scaffold failure.
    Felix C; Everaert B; Jepson N; Tamburino C; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V175-80. PubMed ID: 25983160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable vascular scaffold collapse causes subacute thrombosis.
    Ruiz-Salmerón RJ; Pereira S; de Araujo D
    J Invasive Cardiol; 2014 Jul; 26(7):E98-9. PubMed ID: 24993999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions.
    Capodanno D; Angiolillo DJ
    JACC Cardiovasc Interv; 2017 Mar; 10(5):425-437. PubMed ID: 28279311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds.
    Waksman R
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 4):e20-e24. PubMed ID: 29281608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.
    Dziewierz A; Dudek D
    Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the potential late benefits versus early hazard associated with bioresorbable vascular scaffolds in percutaneous coronary interventions: a Markov decision analytic model.
    Fazel R; Vilain KA; Cohen DJ; Yeh RW
    Coron Artery Dis; 2020 May; 31(3):230-236. PubMed ID: 31658137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-correction property a novel feature of bioresorbable coronary scaffolds.
    Diletti R; Ligthart JM; Ramdhan R; Van Mieghem NM
    Int J Cardiol; 2016 Jul; 214():417-8. PubMed ID: 27088402
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioresorbable vascular scaffold subacute thrombosis and the Kounis syndrome.
    Kounis GN; Soufras GD; Tsigkas G; Kounis NG
    J Invasive Cardiol; 2014 Dec; 26(12):E170-1. PubMed ID: 25481001
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Tanaka A; Jabbour RJ; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.
    Capodanno D; Gori T; Nef H; Latib A; Mehilli J; Lesiak M; Caramanno G; Naber C; Di Mario C; Colombo A; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Pyxaras S; Mattesini A; Naganuma T; Münzel T; Tamburino C
    EuroIntervention; 2015 Feb; 10(10):1144-53. PubMed ID: 25042421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioresorbable Stents: Is This Where We Are Headed?
    Wayangankar SA; Ellis SG
    Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary intervention in 2015: Improvement of long-term outcomes after PCI.
    Zeymer U
    Nat Rev Cardiol; 2016 Feb; 13(2):69-70. PubMed ID: 26763540
    [No Abstract]   [Full Text] [Related]  

  • 19. Design Principles of Bioresorbable Polymeric Scaffolds.
    Kossuth MB; Perkins LEL; Rapoza RJ
    Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.
    Tenekecioglu E; Bourantas C; Abdelghani M; Zeng Y; Silva RC; Tateishi H; Sotomi Y; Onuma Y; Yılmaz M; Serruys PW
    Expert Rev Med Devices; 2016; 13(3):271-86. PubMed ID: 26782080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.